Check Cap Ltd Stock
Your prediction
Check Cap Ltd Stock
Check Cap Ltd shows a slight decrease today, losing -€0.020 (-0.960%) compared to yesterday.
Our community identified positive and negative aspects for Check Cap Ltd stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Check Cap Ltd stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Check Cap Ltd in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Check Cap Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Check Cap Ltd | -0.960% | -1.905% | -12.712% | 68.852% | 5.641% | 51.471% | - |
| Beximco Pharmaceuticals Ltd. GDR | 0.940% | -4.444% | -1.376% | -4.444% | -2.273% | -51.136% | -23.214% |
| Cellectar BioSciences Inc. | 2.820% | -1.389% | -23.656% | 102.857% | 24.561% | -77.097% | - |
| Arca Biopharma | -5.290% | 2.516% | 98.176% | 81.616% | 109.646% | 10.884% | -94.250% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-13
From an initial glance at the financial statements of Check Cap, a pharmaceutical company with the US symbol, it appears that the company has been experiencing some financial challenges. Over the years, the company's balance sheets and income statements reveal issues that may be concerning for investors. In order to provide a better understanding of Check Cap's financial performance, let us dive into a detailed analysis.
Pros
Decreasing Total Liabilities: Over the years, it is evident that Check Cap has successfully reduced its total liabilities. The total liabilities decreased from $4,968,000 in 2021 to $4,129,000 in 2022, potentially showing the company's ability to effectively manage its debt obligations.
.png?locale=us "FinanceClub_UoM")
